Pfizer Seeks EU Approval for Kidney Cancer Drug

by Kathy Jones on  June 3, 2011 at 6:28 PM Drug News
RSS Email Print This Page Comment
American pharmaceutical giant Pfizer has submitted an application to European regulators to approve the use of Axitinib, which is a drug for treating kidney cancer patients.
 Pfizer Seeks EU Approval for Kidney Cancer Drug
Pfizer Seeks EU Approval for Kidney Cancer Drug
Advertisement

Axitinib is consumed orally and has been developed to block receptors that influence tumor growth, blood vessel growth, and spread of cancers.

Advertisement
Pfizer revealed that its application has been accepted by the European Medicines Agency and added that it will be providing more data from the late-stage trial of the drug later this week at the American Society of Clinical Oncology meet.

Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Cancer and Homeopathy Urinary Stones In Children Vesico-Ureteric Reflux Causing UTI in Children Hydronephrosis / Antenatal Counseling Signature Drug Toxicity Kidney Disease Cancer Facts Cancer Tattoos A Body Art 
Advertisement

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive